Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer

被引：0

作者：

Mezeckis, Maris ^{[1
]}

Vesprini, Danny ^{[2
]}

Buryk, Vladyslav ^{[3
]}

Miszczyk, Leszek ^{[4
]}

Vjaters, Egils ^{[5
]}

机构：

[1] Univ Latvia, Sigulda Hosp Ctr Stereotact Radiosurg, Lakstigalas Str 13, LV-2150 Sigulda, Latvia

[2] Univ Toronto, Dept Radiat Oncol, Sunnybrook Odette Canc Ctr, T Wing 2075,Bayview Ave TG 260, Toronto, ON M4N 3M5, Canada

[3] Sigulda Hosp Ctr Stereotact Radiosurg, Lakstigalas Str 13, LV-2150 Sigulda, Latvia

[4] Maria Sklodowska Curie Natl Res Inst Oncol Gliwic, Dept Radiotherapy, Wybrzez Armii Krajowej 15, PL-44102 Gliwice, Poland

[5] Univ Latvia, Ctr Urol, P Stradins Clin Univ Hosp, Pilsonu Str 13, LV-1002 Riga, Latvia

来源：

JOURNAL OF RADIOSURGERY AND SBRT | 2022年 / 8卷 / 02期

关键词：

Intermediate unfavorable; high-risk prostate cancer; SBRT; stereotactic body radiotherapy; RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; MULTICENTER TRIAL; CYBERKNIFE; CONSORTIUM; CARCINOMA; OUTCOMES;

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Stereotactic body radiotherapy (SBRT) is well accepted for low- and intermediate-favorable risk prostate cancer. Available evidence about the application of SBRT in unfavorable- and high-risk prostate cancer is less solid. During last year's multiple variations in treatment, techniques have been reported making comparisons more complicated. This review's objective is to review current evidence in application of SBRT in intermediate unfavourable and high-risk prostate cancer and to outline variations in SBRT treatment techniques and relevant results.

引用

页码：95 / 103

页数：9

共 43 条

[1] Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials [J].

Alayed, Yasir ;

Quon, Harvey ;

Cheung, Patrick ;

Chu, William ;

Chung, Hans T. ;

Vesprini, Danny ;

Ong, Aldrich ;

Chowdhury, Amit ;

Panjwani, Dilip ;

Helou, Joelle ;

Pang, Geordi ;

Korol, Renee ;

Davidson, Melanie ;

Ravi, Ananth ;

McCurdy, Boyd ;

Zhang, Liying ;

Mamedov, Alexandre ;

Deabreu, Andrea ;

Commisso, Angela ;

Commisso, Kristina ;

Loblaw, Andrew .

RADIOTHERAPY AND ONCOLOGY, 2019, 140 :105-109

[2] SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation [J].

Alayed, Yasir ;

Cheung, Patrick ;

Vesprini, Danny ;

Liu, Stanley ;

Chu, William ;

Chung, Hans ;

Musunuru, Hima Bindu ;

Davidson, Melanie ;

Ravi, Ananth ;

Ho, Ling ;

Deabreu, Andrea ;

D'Alimonte, Laura ;

Bhounr, Zeeba ;

Zhang, Liying ;

Commisso, Kristina ;

Loblaw, Andrew .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01) :36-41

[3] Ten-Year Outcomes of High-Dose, Intensity-Modulated Radiotherapy for Localized Prostate Cancer [J].

Alicikus, Zumre A. ;

Yamada, Yoshiya ;

Zhang, Zhigang ;

Pei, Xin ;

Hunt, Margie ;

Kollmeier, Marisa ;

Cox, Brett ;

Zelefsky, Michael J. .

CANCER, 2011, 117 (07) :1429-1437

[4] Stereotactic body radiation therapy: The report of AAPM Task Group 101 [J].

Benedict, Stanley H. ;

Yenice, Kamil M. ;

Followill, David ;

Galvin, James M. ;

Hinson, William ;

Kavanagh, Brian ;

Keall, Paul ;

Lovelock, Michael ;

Meeks, Sanford ;

Papiez, Lech ;

Purdie, Thomas ;

Sadagopan, Ramaswamy ;

Schell, Michael C. ;

Salter, Bill ;

Schlesinger, David J. ;

Shiu, Almon S. ;

Solberg, Timothy ;

Song, Danny Y. ;

Stieber, Volker ;

Timmerman, Robert ;

Tome, Wolfgang A. ;

Verellen, Dirk ;

Wang, Lu ;

Yin, Fang-Fang .

MEDICAL PHYSICS, 2010, 37 (08) :4078-4101

[5] SBRT for the primary treatment of localized prostate cancer: the effect of Gleason score, dose and heterogeneity of intermediate risk on outcome utilizing 2.2014 NCCN risk stratification guidelines [J].

Bernetich, Matthew ;

Oliai, Caspian ;

Lanciano, Rachelle ;

Hanlon, Alexandra ;

Lamond, John ;

Arrigo, Stephen ;

Yang, Jun ;

Good, Michael ;

Feng, Jing ;

Brown, Royce ;

Garber, Bruce ;

Mooreville, Michael ;

Brady, Luther W. .

FRONTIERS IN ONCOLOGY, 2014, 4

[6] Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer [J].

Boyer, Matthew J. ;

Papagikos, Michael A. ;

Kiteley, Rex ;

Vujaskovic, Zeljko ;

Wu, Jackie ;

Lee, W. Robert .

RADIATION ONCOLOGY, 2017, 12

[7] Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial [J].

Brand, Douglas H. ;

Tree, Alison C. ;

Ostler, Peter ;

van der Voet, Hans ;

Loblaw, Andrew ;

Chu, William ;

Ford, Daniel ;

Tolan, Shaun ;

Jain, Suneil ;

Martin, Alexander ;

Staffurth, John ;

Camilleri, Philip ;

Kancherla, Kiran ;

Frew, John ;

Chan, Andrew ;

Dayes, Ian S. ;

Henderson, Daniel ;

Brown, Stephanie ;

Cruickshank, Clare ;

Burnett, Stephanie ;

Duffton, Aileen ;

Griffin, Clare ;

Hinder, Victoria ;

Morrison, Kirsty ;

Naismith, Olivia ;

Hall, Emma ;

van As, Nicholas .

LANCET ONCOLOGY, 2019, 20 (11) :1531-1543

[8] A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis [J].

Callan, Laura ;

Bauman, Glenn ;

Chen, Jeff ;

Lock, Michael ;

Sexton, Tracy ;

D'Souza, David ;

Rodrigues, George .

ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (04) :668-673

[9] MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer [J].

Cuccia, Francesco ;

Corradini, Stefanie ;

Mazzola, Rosario ;

Spiazzi, Luigi ;

Rigo, Michele ;

Bonu, Marco Lorenzo ;

Ruggieri, Ruggero ;

Bastia, Michela Buglione di Monale e ;

Magrini, Stefano Maria ;

Alongi, Filippo .

CANCERS, 2021, 13 (08)

[10] Stereotactic ablative radiotherapy with CyberKnife in the treatment of locally advanced prostate cancer: preliminary results [J].

Fan, Chao-Yueh ;

Chao, Hsing-Lung ;

Huang, Wen-Yen ;

Lin, Chun-Shu ;

Chen, Chang-Ming ;

Lo, Cheng-Hsiang .

TUMORI JOURNAL, 2015, 101 (06) :684-691

← 1 2 3 4 5 →